| 000 | 01634 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515093216.0 | ||
| 264 | 0 | _c20071218 | |
| 008 | 200712s 0 0 fre d | ||
| 022 | _a0037-9085 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aToumi, A | |
| 245 | 0 | 0 |
_a[Demographic, clinical and therapeutic features of adult visceral leishmaniasis at the Rabta hospital in Tunis (tunisia) from 1983 to 2002]. _h[electronic resource] |
| 260 |
_bBulletin de la Societe de pathologie exotique (1990) _cOct 2007 |
||
| 300 |
_a282-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmphotericin B _xtherapeutic use |
| 650 | 0 | 4 |
_aAnemia _xepidemiology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimony _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aFever _xepidemiology |
| 650 | 0 | 4 |
_aHIV Infections _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeishmania infantum _xclassification |
| 650 | 0 | 4 |
_aLeishmaniasis, Visceral _xepidemiology |
| 650 | 0 | 4 |
_aMeglumine _xtherapeutic use |
| 650 | 0 | 4 | _aMeglumine Antimoniate |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSplenomegaly _xepidemiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTunisia _xepidemiology |
| 700 | 1 | _aKilani, B | |
| 700 | 1 | _aAmmari, L | |
| 700 | 1 | _aTiouiri, H | |
| 700 | 1 | _aKanoun, F | |
| 700 | 1 | _aBelhadj, S | |
| 700 | 1 | _aChaker, E | |
| 700 | 1 | _aBen Chaabene, T | |
| 773 | 0 |
_tBulletin de la Societe de pathologie exotique (1990) _gvol. 100 _gno. 4 _gp. 282-6 |
|
| 999 |
_c17500923 _d17500923 |
||